These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22045488)

  • 1. Amyloid-β protein precursor gene expression in alzheimer's disease and other conditions.
    Pottier C; Wallon D; Lecrux AR; Maltete D; Bombois S; Jurici S; Frebourg T; Hannequin D; Campion D
    J Alzheimers Dis; 2012; 28(3):561-6. PubMed ID: 22045488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The French series of autosomal dominant early onset Alzheimer's disease cases: mutation spectrum and cerebrospinal fluid biomarkers.
    Wallon D; Rousseau S; Rovelet-Lecrux A; Quillard-Muraine M; Guyant-Maréchal L; Martinaud O; Pariente J; Puel M; Rollin-Sillaire A; Pasquier F; Le Ber I; Sarazin M; Croisile B; Boutoleau-Bretonnière C; Thomas-Antérion C; Paquet C; Moreaud O; Gabelle A; Sellal F; Sauvée M; Laquerrière A; Duyckaerts C; Delisle MB; Streichenberger N; Lannes B; Frebourg T; Hannequin D; Campion D;
    J Alzheimers Dis; 2012; 30(4):847-56. PubMed ID: 22475797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
    Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT
    Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AbetaPP A713T mutation in late onset Alzheimer's disease with cerebrovascular lesions.
    Bernardi L; Geracitano S; Colao R; Puccio G; Gallo M; Anfossi M; Frangipane F; Curcio SA; Mirabelli M; Tomaino C; Vasso F; Smirne N; Maletta R; Bruni AC
    J Alzheimers Dis; 2009; 17(2):383-9. PubMed ID: 19363265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-amyloid controls altered Reelin expression and processing in Alzheimer's disease.
    Botella-López A; Cuchillo-Ibáñez I; Cotrufo T; Mok SS; Li QX; Barquero MS; Dierssen M; Soriano E; Sáez-Valero J
    Neurobiol Dis; 2010 Mar; 37(3):682-91. PubMed ID: 20025970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional roles of amyloid-beta protein precursor and amyloid-beta peptides: evidence from experimental studies.
    Hiltunen M; van Groen T; Jolkkonen J
    J Alzheimers Dis; 2009; 18(2):401-12. PubMed ID: 19584429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid-beta deposition in the cerebral cortex in Dementia with Lewy bodies is accompanied by a relative increase in AbetaPP mRNA isoforms containing the Kunitz protease inhibitor.
    Barrachina M; Dalfó E; Puig B; Vidal N; Freixes M; Castaño E; Ferrer I
    Neurochem Int; 2005 Feb; 46(3):253-60. PubMed ID: 15670642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of zinc transporter ZnT3 protein in the cerebellar cortex of the AbetaPP/PS1 transgenic mouse.
    Zheng W; Wang T; Yu D; Feng WY; Nie YX; Stoltenberg M; Danscher G; Wang ZY
    J Alzheimers Dis; 2010; 20(1):323-31. PubMed ID: 20164588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calretinin interneurons are early targets of extracellular amyloid-beta pathology in PS1/AbetaPP Alzheimer mice hippocampus.
    Baglietto-Vargas D; Moreno-Gonzalez I; Sanchez-Varo R; Jimenez S; Trujillo-Estrada L; Sanchez-Mejias E; Torres M; Romero-Acebal M; Ruano D; Vizuete M; Vitorica J; Gutierrez A
    J Alzheimers Dis; 2010; 21(1):119-32. PubMed ID: 20413859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-amyloid secretases and beta-amloid degrading enzyme expression in lens.
    Li G; Percontino L; Sun Q; Qazi AS; Frederikse PH
    Mol Vis; 2003 May; 9():179-83. PubMed ID: 12740567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic study of familial cases of Alzheimer's disease.
    Kowalska A; Pruchnik-Wolińska D; Florczak J; Modestowicz R; Szczech J; Kozubski W; Rossa G; Wender M
    Acta Biochim Pol; 2004; 51(1):245-52. PubMed ID: 15094846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment.
    Leon WC; Canneva F; Partridge V; Allard S; Ferretti MT; DeWilde A; Vercauteren F; Atifeh R; Ducatenzeiler A; Klein W; Szyf M; Alhonen L; Cuello AC
    J Alzheimers Dis; 2010; 20(1):113-26. PubMed ID: 20164597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism].
    Panza F; Solfrizzi V; D'Introno A; Capurso C; Colacicco AM; Torres F; Altomare E; Capurso A
    Recenti Prog Med; 2002 Sep; 93(9):489-97. PubMed ID: 12355988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Glu318Gly mutation of the presenilin-1 gene does not necessarily cause Alzheimer's disease.
    Mattila KM; Forsell C; Pirttilä T; Rinne JO; Lehtimäki T; Röyttä M; Lilius L; Eerola A; St George-Hyslop PH; Frey H; Lannfelt L
    Ann Neurol; 1998 Dec; 44(6):965-7. PubMed ID: 9851443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel T719P AbetaPP mutation unbalances the relative proportion of amyloid-beta peptides.
    Ghidoni R; Albertini V; Squitti R; Paterlini A; Bruno A; Bernardini S; Cassetta E; Rossini PM; Squitieri F; Benussi L; Binetti G
    J Alzheimers Dis; 2009; 18(2):295-303. PubMed ID: 19584443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid precursor protein (APP) and beta A4 amyloid in Alzheimer's disease and Down syndrome.
    Beyreuther K; Dyrks T; Hilbich C; Mönning U; König G; Multhaup G; Pollwein P; Masters CL
    Prog Clin Biol Res; 1992; 379():159-82. PubMed ID: 1409743
    [No Abstract]   [Full Text] [Related]  

  • 17. Lesion-induced hippocampal plasticity in transgenic Alzheimer's disease mouse models: influences of age, genotype, and estrogen.
    Kadish I; van Groen T
    J Alzheimers Dis; 2009; 18(2):429-45. PubMed ID: 19584452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frameshift proteins in autosomal dominant forms of Alzheimer disease and other tauopathies.
    van Leeuwen FW; van Tijn P; Sonnemans MA; Hobo B; Mann DM; Van Broeckhoven C; Kumar-Singh S; Cras P; Leuba G; Savioz A; Maat-Schieman ML; Yamaguchi H; Kros JM; Kamphorst W; Hol EM; de Vos RA; Fischer DF
    Neurology; 2006 Jan; 66(2 Suppl 1):S86-92. PubMed ID: 16432153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial Alzheimer's disease: site of mutation influences clinical phenotype.
    Lippa CF; Swearer JM; Kane KJ; Nochlin D; Bird TD; Ghetti B; Nee LE; St George-Hyslop P; Pollen DA; Drachman DA
    Ann Neurol; 2000 Sep; 48(3):376-9. PubMed ID: 10976645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular misreading: the frequency of dinucleotide deletions in neuronal mRNAs for beta-amyloid precursor protein and ubiquitin B.
    Gerez L; de Haan A; Hol EM; Fischer DF; van Leeuwen FW; van Steeg H; Benne R
    Neurobiol Aging; 2005 Feb; 26(2):145-55. PubMed ID: 15582744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.